AZYO Aziyo Biologics, Inc.

Aziyo Biologics, Inc. operates as a biotechnology company which focuses on regenerative medicine in areas such as cardiology, orthopedics and other medical specialties. It offers cardiac device envelope, vascular surgery, cardiothoracic repair, orthopedics and spine, sports medicine, dermal, and wound care. The company was founded on August 6, 2015 and is headquartered in Silver Spring, MD.

As of 12/03/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  10/08/2020
Outstanding shares:  7,122,509
Average volume:  12,915
Market cap:   $33,475,792
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    05479K106
ISIN:        US05479K1060
Valuation   (See tab for details)
PE ratio:   -1.43
PB ratio:   5.54
PS ratio:   0.68
Return on equity:   -268.79%
Net income %:   -43.11%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy